- Home
- PLUS vs IMCR Comparison
PLUS vs IMCR Comparison
Compare PLUS & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUS
- IMCR
- Stock Information
- Founded
- PLUS 1990
- IMCR 2008
- Country
- PLUS United States
- IMCR United Kingdom
- Employees
- PLUS N/A
- IMCR N/A
- Industry
- PLUS Retail: Computer Software & Peripheral Equipment
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLUS Technology
- IMCR Health Care
- Exchange
- PLUS Nasdaq
- IMCR Nasdaq
- Market Cap
- PLUS 2.6B
- IMCR 1.7B
- IPO Year
- PLUS 1996
- IMCR 2021
- Fundamental
- Price
- PLUS $96.76
- IMCR $32.93
- Analyst Decision
- PLUS Hold
- IMCR Buy
- Analyst Count
- PLUS 1
- IMCR 14
- Target Price
- PLUS $90.00
- IMCR $74.75
- AVG Volume (30 Days)
- PLUS 100.1K
- IMCR 267.8K
- Earning Date
- PLUS 11-05-2024
- IMCR 11-05-2024
- Dividend Yield
- PLUS N/A
- IMCR N/A
- EPS Growth
- PLUS N/A
- IMCR N/A
- EPS
- PLUS 4.08
- IMCR N/A
- Revenue
- PLUS $2,195,665,000.00
- IMCR $280,914,000.00
- Revenue This Year
- PLUS $5.69
- IMCR $25.60
- Revenue Next Year
- PLUS $4.68
- IMCR $10.63
- P/E Ratio
- PLUS $24.00
- IMCR N/A
- Revenue Growth
- PLUS 0.56
- IMCR 27.95
- 52 Week Low
- PLUS $53.54
- IMCR $29.72
- 52 Week High
- PLUS $102.99
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- PLUS 52.65
- IMCR 52.76
- Support Level
- PLUS $96.35
- IMCR $31.10
- Resistance Level
- PLUS $99.25
- IMCR $35.47
- Average True Range (ATR)
- PLUS 2.09
- IMCR 1.49
- MACD
- PLUS -0.38
- IMCR 0.17
- Stochastic Oscillator
- PLUS 28.23
- IMCR 51.98
About PLUS ePlus inc.
ePlus Inc is a holding company. ePlus through its subsidiaries provides information technology solutions. The company's technology solutions enable organizations to optimize their IT environment and supply chain processes. It also provides consulting, professional and managed services, and complete lifecycle management services including flexible financing solutions. ePlus focuses on selling to medium and large enterprises in the United States and to customers in select international markets including the United Kingdom, the European Union, India, Singapore and Israel.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.